Saturday, January 09, 2016 5:59:36 PM
This was on YAHOO msg board posted by digitcipher on Jan 7, 2016.
"Imho...if you use a simple yet objective metric....I would say it is worth 30x forward earnings....imho 30x is justified considering the continuously expanding upward momentum in sales and ebitda....that would give 30 x .28 = $8.40.
So if you agree with the ratio, then MEET is worth $8.40 currently. At that price it becomes fairly valued imho, not including the passage of time. As the quarters pass and if the business continues this way, that number will only increase.
What a great position to be in and you don't even have to be lucky....the stock is right there for the taking at this point. Still a ground floor opportunity."
-----------------------------------------------------
@20x=$5.60... hoping for more upside on Monday- but know we are due a pullback after the last couple days. Go MEET!
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM